Crespo MI - Search Results

1

IFNβ produced by TLR4-activated tumor cells is involved in improving the antitumoral immune response.

Núñez NG, Andreani V, Crespo MI, Nocera DA, Breser ML, Morón G, Dejager L, Libert C, Rivero V, Maccioni M. Núñez NG, et al. Among authors: crespo mi. Cancer Res. 2012 Feb 1;72(3):592-603. doi: 10.1158/0008-5472.CAN-11-0534. Epub 2011 Dec 2. Cancer Res. 2012. PMID: 22139376

2

Baculovirus capsid display potentiates OVA cytotoxic and innate immune responses.

Molinari P, Crespo MI, Gravisaco MJ, Taboga O, Morón G. Molinari P, et al. Among authors: crespo mi. PLoS One. 2011;6(8):e24108. doi: 10.1371/journal.pone.0024108. Epub 2011 Aug 30. PLoS One. 2011. PMID: 21918683 Free PMC article.

3

Arginase-dependent suppression by CpG-ODN plus IFA-induced splenic myeloid CD11b(+)Gr1(+) cells.

Ranocchia RP, Gorlino CV, Crespo MI, Harman MF, Liscovsky MV, Morón G, Maletto BA, Pistoresi-Palencia MC. Ranocchia RP, et al. Among authors: crespo mi. Immunol Cell Biol. 2012 Aug;90(7):710-21. doi: 10.1038/icb.2011.98. Epub 2011 Nov 15. Immunol Cell Biol. 2012. PMID: 22083526

4

TLR7 triggering with polyuridylic acid promotes cross-presentation in CD8α+ conventional dendritic cells by enhancing antigen preservation and MHC class I antigen permanence on the dendritic cell surface.

Crespo MI, Zacca ER, Núñez NG, Ranocchia RP, Maccioni M, Maletto BA, Pistoresi-Palencia MC, Morón G. Crespo MI, et al. J Immunol. 2013 Feb 1;190(3):948-60. doi: 10.4049/jimmunol.1102725. Epub 2013 Jan 2. J Immunol. 2013. PMID: 23284054

5

Neutrophils exhibit differential requirements for homing molecules in their lymphatic and blood trafficking into draining lymph nodes.

Gorlino CV, Ranocchia RP, Harman MF, García IA, Crespo MI, Morón G, Maletto BA, Pistoresi-Palencia MC. Gorlino CV, et al. Among authors: crespo mi. J Immunol. 2014 Aug 15;193(4):1966-74. doi: 10.4049/jimmunol.1301791. Epub 2014 Jul 11. J Immunol. 2014. PMID: 25015824

6

Expansion of myeloid-derived suppressor cells with arginase activity lasts longer in aged than in young mice after CpG-ODN plus IFA treatment.

Harman MF, Ranocchia RP, Gorlino CV, Sánchez Vallecillo MF, Castell SD, Crespo MI, Maletto BA, Morón G, Pistoresi-Palencia MC. Harman MF, et al. Among authors: crespo mi. Oncotarget. 2015 May 30;6(15):13448-61. doi: 10.18632/oncotarget.3626. Oncotarget. 2015. PMID: 25922914 Free PMC article.

7

Aging Impairs the Ability of Conventional Dendritic Cells to Cross-Prime CD8+ T Cells upon Stimulation with a TLR7 Ligand.

Zacca ER, Crespo MI, Acland RP, Roselli E, Núñez NG, Maccioni M, Maletto BA, Pistoresi-Palencia MC, Morón G. Zacca ER, et al. Among authors: crespo mi. PLoS One. 2015 Oct 16;10(10):e0140672. doi: 10.1371/journal.pone.0140672. eCollection 2015. PLoS One. 2015. PMID: 26474053 Free PMC article.

8

Class-B CpG-ODN Formulated With a Nanostructure Induces Type I Interferons-Dependent and CD4⁺ T Cell-Independent CD8⁺ T-Cell Response Against Unconjugated Protein Antigen.

Chiodetti AL, Sánchez Vallecillo MF, Dolina JS, Crespo MI, Marin C, Schoenberger SP, Allemandi DA, Palma SD, Pistoresi-Palencia MC, Morón G, Maletto BA. Chiodetti AL, et al. Among authors: crespo mi. Front Immunol. 2018 Oct 10;9:2319. doi: 10.3389/fimmu.2018.02319. eCollection 2018. Front Immunol. 2018. PMID: 30364187 Free PMC article.

9

TLR9 activation is required for cytotoxic response elicited by baculovirus capsid display.

Molinari P, Crespo MI, Molina GN, Dho ND, Marinho FV, Maletto B, Leclerc C, Oliveira SC, Taboga O, Cebrian I, Morón G. Molinari P, et al. Among authors: crespo mi. Immunology. 2023 May;169(1):27-41. doi: 10.1111/imm.13607. Epub 2022 Nov 24. Immunology. 2023. PMID: 36371679 Free article.

10

Improved biodistribution and enhanced immune response of subunit vaccine using a nanostructure formed by self-assembly of ascorbyl palmitate.

Marin C, Ruiz Moreno FN, Sánchez Vallecillo MF, Pascual MM, Dho ND, Allemandi DA, Palma SD, Pistoresi-Palencia MC, Crespo MI, Gomez CG, Morón G, Maletto BA. Marin C, et al. Among authors: crespo mi. Nanomedicine. 2024 Jun;58:102749. doi: 10.1016/j.nano.2024.102749. Epub 2024 May 6. Nanomedicine. 2024. PMID: 38719107

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

32 results

Search Page